141st APHA Annual Meeting

In This section

292674
Establishing a regional disease surveillance network for emerging pathogens along the California-baja California border: Crossing disciplinary, organizational and international boundaries

Wednesday, November 6, 2013 : 9:30 AM - 9:50 AM

Karen Ferran, PhD, MSPH , Graduate School of Public Health, San Diego State University, San Diego, CA
Sarah Marikos, MPH , Graduate School of Public Health, Institute of Public Health, san Diego, CA
Esmeralda Iniguez-Stevens, PhD, MPH , Graduate School of Public Health, San Diego State University, San Diego, CA
Kristine Ortwine, BS , Institute of Public Health, Graduate School of Public Health, San Diego State University, San Diego, CA
The value of transnational disease surveillance in the prevention of regional and worldwide epidemics has increasingly been recognized as multi-country networks for infectious disease surveillance have emerged globally, particularly in conflict or low-resource settings. This paper presents a North American trans-border regional surveillance network established in the California (United States)/Baja California (Mexico) border region to enhance cross-border epidemiologic information exchange and surveillance for emerging pathogens. One Border One Health (OBOH) is a multidisciplinary initiative comprised of over 30 institutions from Mexico and 60 institutions from the United States, with participation from governmental, academic, non-profit, private and military sectors. Professionals with expertise in public health, human and animal medicine, ecology, biology, urban planning, wildlife and environmental health are working in concert rather than in traditionally siloed human, animal, and environmental health sectors. Despite the disparities between health systems, cultures, languages, socioeconomics, politics, animal management strategies, and ecosystems in the region, OBOH is building the infrastructure for a trans-border early warning system, while improving regional infectious disease surveillance capacity and educating a new cadre of students and professionals about One Health. Transnational One Health disease surveillance networks are as critical in North America as they are globally, and should be developed and sustained. Challenges include systematically operationalizing One Health without targeted funding, promoting data exchange, and maintaining equal understanding of One Health surveillance within the initiative as membership increases. This paper provides lessons learned and recommendations on initiating and sustaining cross-border, multidisciplinary, cross-sectoral surveillance, focusing on its strengths, challenges, and future directions.

Learning Areas:
Protection of the public in relation to communicable diseases including prevention or control

Learning Objectives:
Explain why a One Health approach is critical to establishing an early warning surveillance system for emerging pathogens; Describe the advantages of regional disease surveillance networks for preventing the rapid spread of infectious diseases; Describe essential elements of transborder, cross-sectorial, multidisciplinary collaboration and identify potential barriers to effective collaboration.

Keywords: Emerging Diseases, Surveillance

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I was Chief Epidemiologist and Program Manager of the federally funded Early Warning Infectious Disease Surveillance (EWIDS) Program at the California Department of Public Health. EWIDS overarching goal was establishing early warning surveillance for infectious diseases of major public health importance such as bioterrorism agents, emerging pathogens and pandemic influenza. In this role I co-founded One Border One Health, a cross-border surveillance network modeled after internationally recognized regional infectious disease surveillance networks such as MECIDS.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.